Express Scripts Holding Company (NASDAQ:ESRX) Updates FY17 Earnings Guidance
Express Scripts Holding Company (NASDAQ:ESRX) issued an update on its FY17 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $6.95-7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.97. Express Scripts Holding also updated its Q3 guidance to $1.88-1.92 EPS.
Express Scripts Holding Company (NASDAQ ESRX) traded down 0.08% during midday trading on Tuesday, hitting $62.56. 3,461,456 shares of the stock were exchanged. The company has a 50 day moving average price of $62.86 and a 200 day moving average price of $65.32. Express Scripts Holding Company has a one year low of $57.80 and a one year high of $79.24. The firm has a market capitalization of $37.13 billion, a price-to-earnings ratio of 11.34 and a beta of 0.90.
Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.02. Express Scripts Holding had a net margin of 3.42% and a return on equity of 25.64%. The business had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. During the same quarter last year, the firm earned $1.57 EPS. Express Scripts Holding’s quarterly revenue was up .5% compared to the same quarter last year. Equities analysts anticipate that Express Scripts Holding Company will post $6.97 EPS for the current year.
Several research analysts recently weighed in on ESRX shares. ValuEngine lowered shares of Express Scripts Holding from a buy rating to a hold rating in a research note on Friday, June 2nd. Mizuho dropped their target price on shares of Express Scripts Holding from $76.00 to $61.00 and set a neutral rating on the stock in a report on Tuesday, April 25th. Evercore ISI dropped their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an in-line rating on the stock in a report on Wednesday, April 26th. Cowen and Company restated an outperform rating and set a $83.00 target price on shares of Express Scripts Holding in a report on Friday, June 9th. Finally, Edward Jones downgraded shares of Express Scripts Holding from a buy rating to a hold rating in a report on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of Hold and an average target price of $71.89.
In other news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the sale, the vice president now owns 11,108 shares of the company’s stock, valued at $667,368.64. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.68% of the company’s stock.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.